TRAINING ON THE ITAC STUDY PROCEDURES
- September 8, 2020
- Posted by: IHVN
- Category: update
No Comments
![](https://ihvn-irce.org/wp-content/uploads/2016/01/Whealth-3-2-1110x550.jpg)
The training of staff on the ITAC (Inpatient Treatment with Anti-Coronavirus Immunoglobulin) study took place in the month of September, 2020. ITAC is a clinical trial which commences in October 2020. This study will evaluate the potential impact of hyperimmunglobulin as a treatment option in #COVID19 infected patients, who present mild to moderate symptoms.
The Nigerian Principal Investigator has this to say: “We are training the participants to be able to implement the ITAC study procedures for the Nigerian sites.” – Dr. Eriobu Nnakelu, Evaluation Manager IRCE, Principal Investigator START and D2EFF study